Prenatal phthalate exposure and neurodevelopmental delay in early childhood (1 to 3 years): An Environmental influences on Child Health Outcomes (ECHO) study.
Environ Int.
2026 Feb;208:110100. doi: 10.1016/j.envint.2026.110100. Epub 2026 Jan 22. PubMed PMID:
41592363; PubMed Central PMCID:
PMC13033377.
Live microbials to boost Anti-SARS-CoV-2 immunity clinical trial (Live BASIC trial): a triple-blind randomized controlled trial.
Infection.
2026 Feb;54(1):473-485. doi: 10.1007/s15010-025-02697-4. Epub 2025 Nov 26. PubMed PMID:
41299123; PubMed Central PMCID:
PMC12864199.
The role of co-infection in the pathogenesis of acute SARS-CoV-2 infection and development of post-acute sequelae: A perspective.
Elife.
2025 Nov 17;14. doi: 10.7554/eLife.106308. Review. PubMed PMID:
41247781; PubMed Central PMCID:
PMC12622966.
Mass spectrometry combined with machine learning identifies novel protein signatures as demonstrated with multisystem inflammatory syndrome in children.
Sci Rep.
2025 Oct 22;15(1):36843. doi: 10.1038/s41598-025-20684-5. PubMed PMID:
41125642; PubMed Central PMCID:
PMC12546946.
Immune-Mediated Necrotizing Myopathy Diagnosis and Flare in an Adolescent After COVID-19 Vaccine.
Clin Case Rep.
2025 Oct;13(10):e71287. doi: 10.1002/ccr3.71287. eCollection 2025 Oct. PubMed PMID:
41127686; PubMed Central PMCID:
PMC12537298.
Effects of the COVID-19 Pandemic on Pediatric Hospitalizations for Life-Threatening Conditions.
J Pediatr Clin Pract.
2025 Sep;17:200175. doi: 10.1016/j.jpedcp.2025.200175. eCollection 2025 Sep. PubMed PMID:
40989878; PubMed Central PMCID:
PMC12450724.
Factors influencing biospecimen collection in decentralized pregnancy and birth cohorts: A qualitative study.
J Clin Transl Sci.
2025;9(1):e189. doi: 10.1017/cts.2025.10099. eCollection 2025. PubMed PMID:
41069356; PubMed Central PMCID:
PMC12505239.
Cryptococcosis, tuberculosis, and a kidney cancer fail to fit the atherosclerosis paradigm for foam cell lipid content.
J Immunol.
2025 Jun 1;214(6):1358-1369. doi: 10.1093/jimmun/vkaf038. PubMed PMID:
40156376; PubMed Central PMCID:
PMC12207076.
Barriers and strategies for recruitment of pregnant women in contemporary longitudinal birth cohort studies.
BMC Med Res Methodol.
2025 Apr 28;25(1):117. doi: 10.1186/s12874-025-02570-w. PubMed PMID:
40295914; PubMed Central PMCID:
PMC12036123.
A genetically modulated Toll-like receptor-tolerant phenotype in peripheral blood cells of children with multisystem inflammatory syndrome.
J Immunol.
2025 Mar 1;214(3):373-383. doi: 10.1093/jimmun/vkaf006. PubMed PMID:
40101747; PubMed Central PMCID:
PMC11952872.
New Diagnoses of Juvenile Idiopathic Arthritis Early in the COVID-19 Pandemic: Analysis of a Large United States Commercial Insurance Database.
J Clin Rheumatol.
2025 Jan 1;31(1):40-44. doi: 10.1097/RHU.0000000000002154. PubMed PMID:
39705125; PubMed Central PMCID:
PMC11665894.
Approaches and outcomes of adalimumab discontinuation in patients with well-controlled inflammatory arthritis: a systematic search and review.
Pediatr Rheumatol Online J.
2024 Dec 30;22(1):112. doi: 10.1186/s12969-024-01046-3. PubMed PMID:
39734203; PubMed Central PMCID:
PMC11684048.
Current Utilization of Bupropion Treatment in Children, Young Adults, and Adults in the United States.
J Child Adolesc Psychopharmacol.
2024 Dec 20;. doi: 10.1089/cap.2024.0111. [Epub ahead of print] PubMed PMID:
39705092.
Trends in New Use of Disease-Modifying Antirheumatic Drugs for Juvenile Idiopathic Arthritis Among Commercially Insured Children in the United States from 2001 to 2022.
Arthritis Rheumatol.
2025 Apr;77(4):468-476. doi: 10.1002/art.43041. Epub 2024 Dec 10. PubMed PMID:
39435602; PubMed Central PMCID:
PMC11936494.
Severe Cutaneous Adverse Reactions in Hospitalized Children: A Pilot Validation Study.
Pharmacoepidemiol Drug Saf.
2024 Dec;33(12):e70061. doi: 10.1002/pds.70061. PubMed PMID:
39603660; PubMed Central PMCID:
PMC11694326.
Assessments of working group effectiveness in the planning of the New Jersey Kids Study: An applied mixed-methods study on the science of team science.
J Clin Transl Sci.
2024;8(1):e163. doi: 10.1017/cts.2024.578. eCollection 2024. PubMed PMID:
39619065; PubMed Central PMCID:
PMC11604504.
Age and Hair Cortisol Levels as Predictors of SARS-CoV-2 Infection.
Int J Environ Res Public Health.
2024 Sep 2;21(9). doi: 10.3390/ijerph21091166. PubMed PMID:
39338049; PubMed Central PMCID:
PMC11430878.
Long-term recovery of taste and smell following acute COVID-19 infection in a New Jersey cohort.
Sci Talks.
2024 Sep;11. doi: 10.1016/j.sctalk.2024.100390. Epub 2024 Aug 15. PubMed PMID:
39308483; PubMed Central PMCID:
PMC11414579.
Imaging the Architecture of Granulomas Induced by Mycobacterium tuberculosis Infection with Single-molecule Fluorescence In Situ Hybridization.
J Immunol.
2024 Aug 15;213(4):526-537. doi: 10.4049/jimmunol.2300068. PubMed PMID:
38912840; PubMed Central PMCID:
PMC11407750.
Validation of new medication use algorithms as proxies for worsening disease activity in patients with juvenile idiopathic arthritis.
Pharmacoepidemiol Drug Saf.
2024 May;33(5):e5803. doi: 10.1002/pds.5803. PubMed PMID:
38685851; PubMed Central PMCID:
PMC11541400.
Validity of ICD-10-based algorithms to identify patients with influenza in inpatient and outpatient settings.
Pharmacoepidemiol Drug Saf.
2024 Apr;33(4):e5788. doi: 10.1002/pds.5788. PubMed PMID:
38556924; PubMed Central PMCID:
PMC11022168.
CRP Monitoring in Early Hospitalization: Implications for Predicting Outcomes in Patients with COVID-19.
Pathogens.
2023 Nov 4;12(11). doi: 10.3390/pathogens12111315. PubMed PMID:
38003780; PubMed Central PMCID:
PMC10675493.
Acid-suppressive medication and incidence of chronic childhood immune-mediated diseases: A scoping review.
Pediatr Allergy Immunol.
2023 Nov;34(11):e14042. doi: 10.1111/pai.14042. PubMed PMID:
38010007; PubMed Central PMCID:
PMC10683867.
Impact of the COVID-19 Pandemic on the Management of Juvenile Idiopathic Arthritis: Analysis of United States Commercial Insurance Data.
J Clin Rheumatol.
2023 Dec 1;29(8):388-395. doi: 10.1097/RHU.0000000000002035. Epub 2023 Oct 12. PubMed PMID:
37798830; PubMed Central PMCID:
PMC10843854.
Overview of global real-world data sources for pediatric pharmacoepidemiologic research.
Pharmacoepidemiol Drug Saf.
2024 Jan;33(1):e5695. doi: 10.1002/pds.5695. Epub 2023 Sep 10. Review. PubMed PMID:
37690792; PubMed Central PMCID:
PMC10840986.
Saliva microbiome in relation to SARS-CoV-2 infection in a prospective cohort of healthy US adults.
EBioMedicine.
2023 Aug;94:104731. doi: 10.1016/j.ebiom.2023.104731. Epub 2023 Jul 22. PubMed PMID:
37487417; PubMed Central PMCID:
PMC10382861.
Optimizing therapeutic decision-making for off-label medicines use: A scoping review and consensus recommendations for improving practice and research().
Pharmacoepidemiol Drug Saf.
2023 Nov;32(11):1200-1222. doi: 10.1002/pds.5640. Epub 2023 Jun 21. PubMed PMID:
37208845; PubMed Central PMCID:
PMC10543391.
Geographic Trends in Pediatric Psychotropic Medication Dispensing Before and After the Start of the COVID-19 Pandemic.
Psychiatr Serv.
2023 Aug 1;74(8):880-884. doi: 10.1176/appi.ps.20220314. Epub 2023 Feb 8. PubMed PMID:
36751905; PubMed Central PMCID:
PMC10403367.
Prevalence and treatment of mental, behavioral, and developmental disorders in children with co-occurring autism spectrum disorder and attention-deficit/hyperactivity disorder: A population-based study.
Autism Res.
2023 Apr;16(4):855-867. doi: 10.1002/aur.2894. Epub 2023 Jan 16. PubMed PMID:
36644987; PubMed Central PMCID:
PMC10160807.
Longitudinal Analysis of Biologic Correlates of COVID-19 Resolution: Case Report.
Front Med (Lausanne).
2022;9:915367. doi: 10.3389/fmed.2022.915367. eCollection 2022. PubMed PMID:
35783607; PubMed Central PMCID:
PMC9240225.
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging.
Arthritis Rheumatol.
2022 Apr;74(4):570-585. doi: 10.1002/art.42036. Epub 2022 Mar 1. PubMed PMID:
35233961; PubMed Central PMCID:
PMC10127939.
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis.
Arthritis Care Res (Hoboken).
2022 Apr;74(4):521-537. doi: 10.1002/acr.24853. Epub 2022 Mar 1. PubMed PMID:
35233986; PubMed Central PMCID:
PMC10124899.
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging.
Arthritis Care Res (Hoboken).
2022 Apr;74(4):505-520. doi: 10.1002/acr.24839. Epub 2022 Mar 1. PubMed PMID:
35233989; PubMed Central PMCID:
PMC10231687.
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis.
Arthritis Rheumatol.
2022 Apr;74(4):553-569. doi: 10.1002/art.42037. Epub 2022 Mar 1. PubMed PMID:
35233993; PubMed Central PMCID:
PMC10161784.
Equity and the Hazard of Veiled Injustice: A Methodological Reflection on Risk Adjustment.
Pediatrics.
2022 Mar 1;149(Suppl 3). doi: 10.1542/peds.2020-045948G. PubMed PMID:
35230433.
Dichotomy between the humoral and cellular responses elicited by mRNA and adenoviral vector vaccines against SARS-CoV-2.
BMC Med.
2022 Jan 25;20(1):32. doi: 10.1186/s12916-022-02252-0. PubMed PMID:
35073931; PubMed Central PMCID:
PMC8786593.
SuperSelective primer pairs for sensitive detection of rare somatic mutations.
Sci Rep.
2021 Nov 17;11(1):22384. doi: 10.1038/s41598-021-00920-4. PubMed PMID:
34789731; PubMed Central PMCID:
PMC8599793.
Determinants and Dynamics of SARS-CoV-2 Infection in a Diverse Population: 6-Month Evaluation of a Prospective Cohort Study.
J Infect Dis.
2021 Oct 28;224(8):1345-1356. doi: 10.1093/infdis/jiab411. PubMed PMID:
34387310; PubMed Central PMCID:
PMC8436370.
Reduction in gene expression noise by targeted increase in accessibility at gene loci.
Proc Natl Acad Sci U S A.
2021 Oct 19;118(42). doi: 10.1073/pnas.2018640118. PubMed PMID:
34625470; PubMed Central PMCID:
PMC8545487.
Highly versatile antibody binding assay for the detection of SARS-CoV-2 infection and vaccination.
J Immunol Methods.
2021 Dec;499:113165. doi: 10.1016/j.jim.2021.113165. Epub 2021 Oct 9. PubMed PMID:
34634317; PubMed Central PMCID:
PMC8500840.
Real-World Evidence for Assessing Treatment Effectiveness and Safety in Pediatric Populations.
J Pediatr.
2021 Nov;238:312-316. doi: 10.1016/j.jpeds.2021.06.062. Epub 2021 Jul 2. PubMed PMID:
34217767; PubMed Central PMCID:
PMC8249672.
Medications for Multiple Sclerosis and Risk of Malignancy: What Next?.
Neurotherapeutics.
2021 Jul;18(3):1650-1653. doi: 10.1007/s13311-021-01107-5. Epub 2021 Aug 18. Review. PubMed PMID:
34409568; PubMed Central PMCID:
PMC8608937.
Trends in opioid prescribing at outpatient visits for psoriasis and psoriatic arthritis.
Br J Dermatol.
2021 Jul;185(1):200-201. doi: 10.1111/bjd.19865. Epub 2021 Mar 18. PubMed PMID:
33544885; PubMed Central PMCID:
PMC8254765.
Prevalence of SARS-CoV-2 infection in previously undiagnosed health care workers in New Jersey, at the onset of the U.S. COVID-19 pandemic.
BMC Infect Dis.
2020 Nov 16;20(1):853. doi: 10.1186/s12879-020-05587-2. PubMed PMID:
33198725; PubMed Central PMCID:
PMC7668027.
Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Hospital Workers: Results From a Screening Study in New Jersey, United States in Spring 2020.
Open Forum Infect Dis.
2020 Dec;7(12):ofaa534. doi: 10.1093/ofid/ofaa534. eCollection 2020 Dec. PubMed PMID:
33403219; PubMed Central PMCID:
PMC7665723.
The anti-tubercular activity of simvastatin is mediated by cholesterol-driven autophagy via the AMPK-mTORC1-TFEB axis.
J Lipid Res.
2020 Dec;61(12):1617-1628. doi: 10.1194/jlr.RA120000895. Epub 2020 Aug 26. PubMed PMID:
32848049; PubMed Central PMCID:
PMC7707180.
Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Is Comparable in Clinical Samples Preserved in Saline or Viral Transport Medium.
J Mol Diagn.
2020 Jul;22(7):871-875. doi: 10.1016/j.jmoldx.2020.04.209. Epub 2020 May 13. PubMed PMID:
32405270; PubMed Central PMCID:
PMC7219422.
Lipid-laden macrophages as biomarkers of vaping-associated lung injury.
Lancet Respir Med.
2020 Feb;8(2):e6. doi: 10.1016/S2213-2600(19)30476-X. PubMed PMID:
32035068; PubMed Central PMCID:
PMC7297059.
Foam Cells: One Size Doesn't Fit All.
Trends Immunol.
2019 Dec;40(12):1163-1179. doi: 10.1016/j.it.2019.10.002. Epub 2019 Nov 12. Review. PubMed PMID:
31732284; PubMed Central PMCID:
PMC6925453.
Revisiting John Snow to Meet the Challenge of Nontuberculous Mycobacterial Lung Disease.
Int J Environ Res Public Health.
2019 Nov 1;16(21). doi: 10.3390/ijerph16214250. Review. PubMed PMID:
31683836; PubMed Central PMCID:
PMC6862550.
What would you like to do?